Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Levi

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Recenti Progressi in Medicina|January 31, 2024
[Rare disease in the age of artificial intelligence.]Carlo Alfredo Clerici, Saba Chopard, Giuseppe Levi
Scientific Reports|December 23, 2022
A network approach for low dimensional signatures from high throughput dataNico Curti, Giuseppe Levi, Enrico Giampieri, et al.
Oncotarget|November 18, 2015
The genetic and genomic background of multiple myeloma patients achieving complete response after induction therapy with bortezomib, thalidomide and dexamethasone (VTD)Carolina Terragna, Daniel Remondini, Marina Martello, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Recenti Progressi in Medicina|January 31, 2024
[Rare disease in the age of artificial intelligence.]Carlo Alfredo Clerici, Saba Chopard, Giuseppe Levi
Scientific Reports|December 23, 2022
A network approach for low dimensional signatures from high throughput dataNico Curti, Giuseppe Levi, Enrico Giampieri, et al.
Oncotarget|November 18, 2015
The genetic and genomic background of multiple myeloma patients achieving complete response after induction therapy with bortezomib, thalidomide and dexamethasone (VTD)Carolina Terragna, Daniel Remondini, Marina Martello, et al.
Pageof 1